本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

51.85
-1.5400-2.88%
成交量:37.84万
成交额:1,982.90万
市值:50.14亿
市盈率:-10.89
高:53.20
开:52.91
低:51.85
收:53.39
52周最高:78.00
52周最低:44.12
股本:9,669.26万
流通股本:9,316.62万
量比:0.43
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率:-26.09%
总资产收益率:-14.20%
市净率:2.87
市盈率(LYR):-8.01

数据加载中...

2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]